Laure Allard Ph.D

Principal Scientist and Data Scientist at AliveDx
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Lyon Area, FR
Languages
  • Français -
  • Anglais -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Switzerland
    • Medical Device
    • 100 - 200 Employee
    • Principal Scientist and Data Scientist
      • Oct 2022 - Present

    • France
    • Biotechnology Research
    • 700 & Above Employee
    • Staff Scientist and Data Scientist for R&D department
      • Sep 2016 - Sep 2023

      Support to R&D teams in design of studies and statistical analysis of biological data. Transversal activities and communication Training sessions to R&D teams Methodological sheets redaction Technical expertise in immuno-assay development Scientific expertise in acute (traumatic brain injury and stroke) and chronic brain injury

    • Associate Staff Scientist : Technical leader in automated IVD immuno-assays development
      • Mar 2006 - Feb 2017

      * Development of IVD assays on the VIDAS immuno-assay automate - development of an automated diagnostic test for patient with mild traumatic brain injury (test ready for clinical trial) - development of VIDAS EBV EBNA IgG assay. Commercially available in Europe since 2009. - development of the Galectin-3 recombinant antigen used as control and calibrator in the VIDAS Gal-3 assay (heart failure). Commercially available since 2013. * Development of hsTNI assay on Point of Care… Show more * Development of IVD assays on the VIDAS immuno-assay automate - development of an automated diagnostic test for patient with mild traumatic brain injury (test ready for clinical trial) - development of VIDAS EBV EBNA IgG assay. Commercially available in Europe since 2009. - development of the Galectin-3 recombinant antigen used as control and calibrator in the VIDAS Gal-3 assay (heart failure). Commercially available since 2013. * Development of hsTNI assay on Point of Care Magnotech Minicare system (Philips Handheld Diagnostics) Participation to advisory boards with KOL in the field of biomarkers of brain damages. Project management : training to Kepner-Tregoe method Softwares : Microsoft Office (Word, Excel, Powerpoint, Notes) Statistics (Analyse-it, Statgraphics, Spotfire, miniTab, GraphPad) Planisware 2 IVD assays commercialized 1 IVD assay ready for clinical trial 1 patent more than 120 powerpoint presentations (technic, scientific or stategic)

    • Switzerland
    • Research Services
    • 700 & Above Employee
    • Research Associate Scientist
      • Feb 2002 - Feb 2006

      Discovery and validation of early plasma biomarkers of stroke. - Proteomics technologies (SELDI-TOF, electrophoresis), immunoassays. biostatistical analysis of the data. - Set up of a research clinical trial (collaborations, funding, ethical commitee, creation of a database, organization of samples collection) - Presentation to IVD companies and congresses. Publications : - 10 peer review articles - 3 chapters of book - 3 patents - 5 oral communications in… Show more Discovery and validation of early plasma biomarkers of stroke. - Proteomics technologies (SELDI-TOF, electrophoresis), immunoassays. biostatistical analysis of the data. - Set up of a research clinical trial (collaborations, funding, ethical commitee, creation of a database, organization of samples collection) - Presentation to IVD companies and congresses. Publications : - 10 peer review articles - 3 chapters of book - 3 patents - 5 oral communications in international meetings - 9 posters Show less Discovery and validation of early plasma biomarkers of stroke. - Proteomics technologies (SELDI-TOF, electrophoresis), immunoassays. biostatistical analysis of the data. - Set up of a research clinical trial (collaborations, funding, ethical commitee, creation of a database, organization of samples collection) - Presentation to IVD companies and congresses. Publications : - 10 peer review articles - 3 chapters of book - 3 patents - 5 oral communications in… Show more Discovery and validation of early plasma biomarkers of stroke. - Proteomics technologies (SELDI-TOF, electrophoresis), immunoassays. biostatistical analysis of the data. - Set up of a research clinical trial (collaborations, funding, ethical commitee, creation of a database, organization of samples collection) - Presentation to IVD companies and congresses. Publications : - 10 peer review articles - 3 chapters of book - 3 patents - 5 oral communications in international meetings - 9 posters Show less

    • France
    • Biotechnology Research
    • 700 & Above Employee
    • Ph.D in Biological and Medical Engineering
      • Sep 1998 - Nov 2001

      Oriented immobilization of recombinant proteins derived from the p24 capsid of HIV-1 onto copolymers. Study of the coupling efficiency and the resulting biological activity Publications : - 4 peer review articles - 2 patents - 1 oral communication

    • Master Degree Student
      • Sep 1997 - Sep 1998

      Purification and characterization of a protein inducing apoptosis in multiple sclerosis.

Education

  • Université Claude Bernard Lyon 1
    Master 2 (M2), B3S Biostatistic, Biomathematic Bioinformatic and Health
    2018 - 2019
  • Université Claude Bernard Lyon 1
    DEA (equivalent Master 2 Research), Biological and Medical Engineering
    1997 - 1998
  • Université d'Orléans
    Maitrise des Sciences et Techniques (equivalent Master 1), Biotechnology (biochemistry, microbiology, molecular biology)
    1995 - 1997

Community

You need to have a working account to view this content. Click here to join now